Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.
Clinical trial NCT02516098 · COMPLETED
Trial details
- NCT number
- NCT02516098
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.